This analysis demonstrates value and innovation of direct-acting antivirals for the treatment of chronic hepatitis C in the US Kaiser Permanente health system.
Use of Second-Generation Antidiabetic Medication Among a Nationally Representative Sample
October 19th 2023Among individuals with a diagnosis of type 2 diabetes across the United States, income level, hemoglobin A1c, and comorbidity burden were the primary patient-level drivers of the use of newer antidiabetic agents.
Conversion Miscalculation Found
October 19th 2023Correction to the article “Antineutrophil Cytoplasmic Antibody (ANCA) Vasculitis: Pathophysiology, Diagnosis, and the Evolving Treatment Landscape” published in a September 2021 supplement to The American Journal of Managed Care.
Impact of the Collaborative Care Model on Medical Spending
Modest spending on integrated mental health services in primary care, facilitated by use of new collaborative care billing codes, did not increase overall health care costs.
Health Care Costs of COVID-19 vs Influenza and Pneumonia
COVID-19 health care costs are significantly greater than those for influenza and pneumonia. Treatment costs for severe COVID-19 exceed those for influenza and pneumonia by approximately $50,000.
Spending Patterns Among Commercially Insured Individuals During the COVID-19 Pandemic
In this analysis of more than 97 million commercially insured individuals, investigators found that the COVID-19 pandemic induced a spending shock in 2020 and that health care spending did not recover to baseline until mid-2021.
Care Coordination in Primary Care: Mapping the Territory
A survey completed by 100% of leaders of diverse care systems in Minnesota participating in an observational study showed little difference in approach to care coordination.
Choosing Wisely Interventions to Reduce Antibiotic Overuse in the Safety Net
This study evaluates the impact of Choosing Wisely–based interventions on antibiotic prescribing for viral respiratory tract infections in a real-world safety-net setting.